SPTLC2

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, SPTLC2 mutation is significantly associated with the RNA expression of many other genes, with 5,929 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible SPTLC2-associated genes across cancer lineages are MIR548Q, ATP6V1E1P2, and SNX3P1Y. Each is linked with SPTLC2 in more than 1 cancer types. Because this analysis shows association rather than direction, both SPTLC2-to-partner and partner-to-SPTLC2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, MIR548Q grouped by SPTLC2-low versus SPTLC2-high in KIRP.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (SPTLC2→partner) and Y-score (partner→SPTLC2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
KIRPMIR548Q →+0.499+6.103<.001.00232
UCECATP6V1E1P2 →+0.144+1.829<.001.00432
UCECSNX3P1Y →+0.065+3.834<.001.00732
BRCAKRTAP19-3 →+0.083+5.971.001.00232
COADRNU6-1064P →+0.451+3.321<.001.00832
COADSS18L2P2 →+0.146+4.595<.001.00432
Each partner links to its Q-omics profile. Showing the 6 strongest of 5,929 associations by consensus.

MIR548Q by SPTLC2 expression — KIRP

Box plot of MIR548Q in SPTLC2-low vs SPTLC2-high samples in KIRP.

Explore this box plot interactively →

Exploration